CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 10.52 -1.48 (-12.33%) As of 10/13/2025 10:59 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 16.89%, with a year-to-date return of 5.20%. In the past month, the stock has increased 21.48%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 10.52 with a market cap of £4.20 million and volume of 34,127 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-10.09%1 Month Performance+21.48%3 Month Performance-2.14%Year-To-Date Performance+5.20%1 Year Performance+16.89% CRTX Stock Chart for Tuesday, October, 14, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025GBX 12GBX 10.52-12.33%GBX 12GBX 10.5234,127 shs£4.20 million10/10/2025GBX 11.70GBX 12+2.56%GBX 12GBX 10.56571 shs£4.80 million10/09/2025GBX 10.82GBX 11.70+8.13%GBX 12.82GBX 1080,432 shs£4.68 million10/08/2025GBX 10.24GBX 10.82+5.66%GBX 12GBX 1093,279 shs£4.32 million10/07/2025GBX 11.08GBX 10.24-7.58%GBX 11.84GBX 1017,550 shs£4.09 million10/06/2025GBX 11.70GBX 11.08-5.30%GBX 12GBX 1036,774 shs£4.43 million10/03/2025GBX 10.93GBX 11.70+7.09%GBX 12GBX 11.0230,629 shs£4.68 million10/02/2025GBX 12GBX 10.93-8.96%GBX 12GBX 107,620 shs£4.37 million10/01/2025GBX 9.11GBX 12+31.69%GBX 12GBX 9.2530,583 shs£4.80 million09/30/2025GBX 10.94GBX 9.11-16.71%GBX 10.80GBX 9.1138,575 shs£3.64 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025GBX 8.45GBX 10.94+29.47%GBX 11GBX 853,218 shs£4.37 million09/26/2025GBX 11GBX 8.45-23.18%GBX 11GBX 8219 shs£3.38 million09/25/2025GBX 11GBX 11GBX 11GBX 810,825 shs£4.40 million09/24/2025GBX 8GBX 11+37.50%GBX 11GBX 830,560 shs£4.40 million09/23/2025GBX 11GBX 8-27.27%GBX 10.94GBX 8805,386 shs£3.20 million09/22/2025GBX 10.30GBX 11+6.80%GBX 11GBX 823,801 shs£4.40 million09/19/2025GBX 10.50GBX 10.30-1.90%GBX 11GBX 8.7479,663 shs£4.12 million09/18/2025GBX 10.50GBX 10.50GBX 10.50GBX 8.7199,373 shs£4.20 million09/17/2025GBX 10.20GBX 10.50+2.94%GBX 10.50GBX 8.7199,373 shs£4.20 million09/16/2025GBX 10.50GBX 10.20-2.86%GBX 10.50GBX 940,466 shs£4.08 million09/15/2025GBX 8.66GBX 10.50+21.25%GBX 10.50GBX 899,479 shs£4.20 million Related Companies Celsius Resources Stock Price Chart Landore Resources Stock Price Chart Bezant Resources Stock Price Chart Power Metal Resources Stock Price Chart Tungsten West Stock Price Chart Artemis Resources Stock Price Chart Cloudbreak Discovery Stock Price Chart Galileo Resources Stock Price Chart Vast Resources Stock Price Chart Strategic Minerals Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
